SYnAbs SA
PrivateLast Round
Grant
Dec 1, 2022
Total Funding Raised
$630,000
Company Overview
SYnAbs SA is a biotechnology company that specializes in the development and production of innovative monoclonal antibodies for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SYnAbs SA Comparables
Compare SYnAbs SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biolabs | 85% | |
| Precision Antibody | 82% | |
| BIOTEM | 81% |
SYnAbs SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2022 | ||||
| Grant | Mar 19, 2021 | ||||
| Seed | Sep 14, 2015 |
SYnAbs SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Biotech Investissement | Seed |
| Université catholique de Louvain | Seed |
| Walloon Region (Belgium) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2025
Developing monoclonal antibodies for HbC-specific detection.
- Dec 1, 2022
$630K grant round led by European Innovation Council Fund.
SYnAbs SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SYnAbs SA's valuation, stock price, and market status.
Is SYnAbs SA a public or private company?
SYnAbs SA is a private company.
What is the current stock price of SYnAbs SA?
SYnAbs SA is a private company with no public stock price. No recent secondary market data is available.
How much is SYnAbs SA worth (valuation)?
Valuation information for SYnAbs SA is not publicly available.
Can I buy SYnAbs SA stock?
SYnAbs SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SYnAbs SA's last funding round?
SYnAbs SA's most recent funding round was Grant on December 1, 2022.
Who are the main investors in SYnAbs SA?
Key investors in SYnAbs SA include European Innovation Council Fund, Biotech Investissement, Walloon Region (Belgium).
Will SYnAbs SA IPO soon?
No public IPO plans have been announced for SYnAbs SA.
How can I track SYnAbs SA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SYnAbs SA's secondary market activity and sign up for updates.